The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
RITUXIMAB Steatohepatitis 1
RITUXIMAB Streptococcal bacteraemia 1
RITUXIMAB Streptococcus test positive 1
RITUXIMAB Subarachnoid haemorrhage 1
RITUXIMAB Subdural haematoma 1
Rituximab Superinfection 1
Rituximab Superior vena cava syndrome 1
RITUXIMAB Supraventricular tachycardia 1
Rituximab Suspected transmission of an infectious agent via product 1
RITUXIMAB Swelling 1
Rituximab Synovectomy 1
Rituximab Systemic lupus erythematosus 1
RITUXIMAB Systemic mycosis 1
Rituximab Tendon rupture 1
Rituximab Tendon sheath incision 1
RITUXIMAB Therapy cessation 1
RITUXIMAB Thrombotic thrombocytopenic purpura 1
Rituximab Thyroid cancer 1
RITUXIMAB Tinnitus 1
RITUXIMAB Transaminases abnormal 1

Total Records: 1,104     Number of Pages: 56